- Home
- PRTA vs MLP Comparison
PRTA vs MLP Comparison
Compare PRTA & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- MLP
- Stock Information
- Founded
- PRTA 2012
- MLP 1909
- Country
- PRTA Ireland
- MLP United States
- Employees
- PRTA N/A
- MLP N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- MLP Real Estate
- Sector
- PRTA Health Care
- MLP Finance
- Exchange
- PRTA Nasdaq
- MLP Nasdaq
- Market Cap
- PRTA 472.1M
- MLP 343.9M
- IPO Year
- PRTA N/A
- MLP 1972
- Fundamental
- Price
- PRTA $8.20
- MLP $17.50
- Analyst Decision
- PRTA Buy
- MLP
- Analyst Count
- PRTA 10
- MLP 0
- Target Price
- PRTA $14.86
- MLP N/A
- AVG Volume (30 Days)
- PRTA 1.2M
- MLP 15.7K
- Earning Date
- PRTA 08-04-2025
- MLP 08-14-2025
- Dividend Yield
- PRTA N/A
- MLP N/A
- EPS Growth
- PRTA N/A
- MLP N/A
- EPS
- PRTA N/A
- MLP N/A
- Revenue
- PRTA $10,341,000.00
- MLP $16,843,000.00
- Revenue This Year
- PRTA N/A
- MLP N/A
- Revenue Next Year
- PRTA $389.77
- MLP N/A
- P/E Ratio
- PRTA N/A
- MLP N/A
- Revenue Growth
- PRTA N/A
- MLP 74.59
- 52 Week Low
- PRTA $4.32
- MLP $14.05
- 52 Week High
- PRTA $22.83
- MLP $26.46
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- MLP 53.69
- Support Level
- PRTA $8.05
- MLP $16.41
- Resistance Level
- PRTA $8.73
- MLP $17.49
- Average True Range (ATR)
- PRTA 0.38
- MLP 0.56
- MACD
- PRTA -0.05
- MLP 0.10
- Stochastic Oscillator
- PRTA 47.62
- MLP 81.63
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.